The license supports domestic capability to recover and prepare isotope materials used across medicine, research, advanced manufacturing, and national security, and enables Atomic Alchemy to begin initial commercial sales from its Idaho Radiochemistry Laboratory.

Oklo Inc., (NYSE:OKLO) (Oklo), an advanced nuclear technology company, today announced that the U.S. Nuclear Regulatory Commission (NRC) has issued a materials license to Oklo's wholly owned subsidiary Atomic Alchemy to handle, process, and distribute isotopes. This is Oklo's first NRC-issued license and supports the transition from design and planning to real-world execution and progress.